Department of Periodontics, University of Texas School of Dentistry at Houston, Houston, TX, USA.
Am J Kidney Dis. 2013 Mar;61(3):450-8. doi: 10.1053/j.ajkd.2012.10.021. Epub 2012 Dec 20.
Periodontitis is a novel risk factor for inflammation and cardiovascular disease in the dialysis population. Limited information exists about the impact of periodontal therapy in patients receiving dialysis.
Randomized controlled trial to assess feasibility and gather preliminary data.
SETTING & PARTICIPANTS: Dialysis patients with moderate/severe chronic periodontitis.
Intensive treatment, consisting of scaling and root planing, extraction of hopeless teeth, and placement of local-delivery antibiotics, was performed at the baseline visit for treatment-group patients and after study completion for control-group patients.
Outcomes were feasibility (screening, recruitment, enrollment, adverse events, and study withdrawal/completion), clinical periodontal parameters (probing depth, clinical attachment level, bleeding on probing, gingival index, and plaque index), and serum albumin and interleukin 6 levels at 3 and 6 months postintervention.
342 dialysis patients were approached for participation: 53 were randomly assigned, with 26 participants assigned to immediate treatment and 27 assigned to a control arm for treatment after 6 months. 51 patients completed baseline appointments; 46 were available for 3-month follow-up, 45 were available for 6-month follow-up examinations, and 43 completed all visits. At 3 months, there was a statistically significant improvement for the treatment group compared to the control group for 3 periodontal parameters: mean probing depth (P = 0.008), extent of probing depth ≥4 mm (P = 0.02), and extent of gingival index ≥1 (P = 0.01). However, by 6 months, the difference between groups was no longer present for any variable except probing depth ≥4 mm (P = 0.04). There was no significant difference between groups for serum albumin or high-sensitivity interleukin 6 level at any time when adjusted for body mass index, diabetic status, and plaque index.
Small sample size and relatively healthy population, imbalance in diabetes.
This small trial demonstrates successful cooperation between dentists and nephrologists and successful recruitment, treatment, and retention of dialysis patients with periodontitis. Larger studies with longer follow-up are needed to determine whether treatment can improve markers of inflammation and morbidity.
牙周炎是透析人群中炎症和心血管疾病的新的危险因素。关于牙周治疗对接受透析的患者的影响,相关信息有限。
评估可行性并收集初步数据的随机对照试验。
患有中重度慢性牙周炎的透析患者。
治疗组患者在基线就诊时进行强化治疗,包括洁治和根面平整、拔除无望的牙齿以及局部给予抗生素;对照组患者在研究完成后进行治疗。
结局包括可行性(筛选、招募、入组、不良事件和研究退出/完成)、临床牙周参数(探诊深度、临床附着水平、探诊出血、牙龈指数和菌斑指数)以及干预后 3 个月和 6 个月时的血清白蛋白和白细胞介素 6 水平。
共有 342 名透析患者被邀请参与研究,其中 53 名被随机分配,26 名患者被分配至即刻治疗组,27 名患者被分配至对照组,在 6 个月后接受治疗。51 名患者完成了基线预约;46 名患者可进行 3 个月随访,45 名患者可进行 6 个月随访检查,43 名患者完成了所有就诊。在 3 个月时,治疗组的 3 项牙周参数与对照组相比有统计学显著改善:平均探诊深度(P = 0.008)、探诊深度≥4mm 的程度(P = 0.02)和牙龈指数≥1 的程度(P = 0.01)。然而,在 6 个月时,除了探诊深度≥4mm 外(P = 0.04),两组之间的差异不再存在。在调整体重指数、糖尿病状态和菌斑指数后,两组在任何时间的血清白蛋白或高敏白细胞介素 6 水平均无显著差异。
样本量小且人群相对健康,糖尿病存在不均衡。
这项小型试验表明,牙医和肾病学家之间成功合作,成功招募、治疗和保留了患有牙周炎的透析患者。需要进行更大规模的随访时间更长的研究,以确定治疗是否可以改善炎症和发病率的标志物。